-
2
-
-
79958043675
-
-
National Cancer Institute. B ethesda MD [online]
-
Howlader N. et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute. B ethesda, MD [online] http://seer.cancer.gov/csr/1975-2010/ (2013
-
(2013)
SEER Cancer Statistics Review 1975-2010
-
-
Howlader, N.1
-
3
-
-
70450190156
-
-
Canadian Cancer Societys Advisory Committee on Cancer Statistics. Canadian Cancer Society
-
Canadian Cancer Societys Advisory Committee on Cancer Statistics. Canadian Cancer Statistics, Toronto, ON. Canadian Cancer Society (2013
-
(2013)
Canadian Cancer Statistics, Toronto, on
-
-
-
4
-
-
84859388765
-
Pathogenesis of human B cell lymphomas
-
Shaffer, A. L. 3rd, Young, R. M. & Staudt, L. M. Pathogenesis of human B cell lymphomas. Annu. Rev. Immunol. 30, 565-610 (2012
-
(2012)
Annu. Rev. Immunol
, vol.30
, pp. 565-610
-
-
Shaffer III, A.L.1
Young, R.M.2
Staudt, L.M.3
-
5
-
-
79952284127
-
Hallmarks of cancer: The next generation
-
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
6
-
-
84867051939
-
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
-
Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116-120 (2012
-
(2012)
Nature
, vol.490
, pp. 116-120
-
-
Schmitz, R.1
-
7
-
-
79961158055
-
Follicular regulatory T cells expressing Foxp3 and Bcl 6 suppress germinal center reactions
-
Chung, Y. et al. Follicular regulatory T cells expressing Foxp3 and Bcl 6 suppress germinal center reactions. Nature Med. 17, 983-988 (2011
-
(2011)
Nature Med
, vol.17
, pp. 983-988
-
-
Chung, Y.1
-
8
-
-
79961151137
-
Foxp3+ follicular regulatory T cells control the germinal center response
-
Linterman, M. A. et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nature Med. 17, 975-982 (2011
-
(2011)
Nature Med
, vol.17
, pp. 975-982
-
-
Linterman, M.A.1
-
9
-
-
84857883847
-
Macrophage plasticity and polarization: In vivo veritas
-
Sica, A. & Mantovani, A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Invest. 122, 787-795 (2012
-
(2012)
J. Clin. Invest
, vol.122
, pp. 787-795
-
-
Sica, A.1
Mantovani, A.2
-
10
-
-
84891535219
-
Defining characteristics of classical Hodgkin lymphoma microenvironment T helper cells
-
Greaves, P. et al. Defining characteristics of classical Hodgkin lymphoma microenvironment T helper cells. Blood 122, 2856-2863 (2013
-
(2013)
Blood
, vol.122
, pp. 2856-2863
-
-
Greaves, P.1
-
11
-
-
79955877897
-
Molecular pathogenesis of Hodgkins lymphoma: Increasing evidence of the importance of the microenvironment
-
Steidl, C., Connors, J. M. & Gascoyne, R. D. Molecular pathogenesis of Hodgkins lymphoma: Increasing evidence of the importance of the microenvironment. J. Clin. Oncol. 29, 1812-1826 (2011
-
(2011)
J. Clin. Oncol
, vol.29
, pp. 1812-1826
-
-
Steidl, C.1
Connors, J.M.2
Gascoyne, R.D.3
-
12
-
-
36148999015
-
Lymphoma dissemination: The other face of lymphocyte homing
-
DOI 10.1182/blood-2007-05-075176
-
Pals, S. T., De Gorter, D. J. & Spaargaren, M. Lymphoma dissemination: The other face of lymphocyte homing. Blood 110, 3102-3111 (2007 (Pubitemid 350106300)
-
(2007)
Blood
, vol.110
, Issue.9
, pp. 3102-3111
-
-
Pals, S.T.1
De Gorter, D.J.J.2
Spaargaren, M.3
-
13
-
-
3442891136
-
Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination
-
DOI 10.1189/jlb.1203652
-
Lopez-Giral, S. et al. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J. Leukoc. Biol. 76, 462-471 (2004 (Pubitemid 39006961)
-
(2004)
Journal of Leukocyte Biology
, vol.76
, Issue.2
, pp. 462-471
-
-
Lopez-Giral, S.1
Quintana, N.E.2
Cabrerizo, M.3
Alfonso-Perez, M.4
Sala-Valdes, M.5
Gomez Garcia De Soria, V.6
Fernandez-Ranada, J.M.7
Fernandez-Ruiz, E.8
Munoz, C.9
-
14
-
-
70349873329
-
Identification of a chemokine receptor profile characteristic for mediastinal large B cell lymphoma
-
Rehm, A. et al. Identification of a chemokine receptor profile characteristic for mediastinal large B cell lymphoma. Int. J. Cancer 125, 2367-2374 (2009
-
(2009)
Int. J. Cancer
, vol.125
, pp. 2367-2374
-
-
Rehm, A.1
-
15
-
-
79961008660
-
Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within secondary lymphoid organs
-
Rehm, A. et al. Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within secondary lymphoid organs. Blood 118, 1020-1033 (2011
-
(2011)
Blood
, vol.118
, pp. 1020-1033
-
-
Rehm, A.1
-
16
-
-
0035073349
-
Relative distribution of tumour cells and reactive cells in follicular lymphoma
-
DOI 10.1002/path.820
-
Su, W., Spencer, J. & Wotherspoon, A. C. Relative distribution of tumour cells and reactive cells in follicular lymphoma. J. Pathol. 193, 498-504 (2001 (Pubitemid 32266819)
-
(2001)
Journal of Pathology
, vol.193
, Issue.4
, pp. 498-504
-
-
Su, W.1
Spencer, J.2
Wotherspoon, A.C.3
-
17
-
-
0037085793
-
Tumor cell dissemination in follicular lymphoma
-
DOI 10.1182/blood.V99.6.2192
-
Oeschger, S., Bräuninger, A., Küppers, R. & Hansmann, M. L. Tumor cell dissemination in follicular lymphoma. Blood 99, 2192-2198 (2002 (Pubitemid 34525506)
-
(2002)
Blood
, vol.99
, Issue.6
, pp. 2192-2198
-
-
Oeschger, S.1
Brauninger, A.2
Kuppers, R.3
Hansmann, M.-L.4
-
18
-
-
73949107840
-
Germinal center reutilization by newly activated B cells
-
Schwickert, T. A., Alabyev, B., Manser, T. & Nussenzweig, M. C. Germinal center reutilization by newly activated B cells. J. Exp. Med. 206, 2907-2914 (2009
-
(2009)
J. Exp. Med
, vol.206
, pp. 2907-2914
-
-
Schwickert, T.A.1
Alabyev, B.2
Manser, T.3
Nussenzweig, M.C.4
-
19
-
-
34948875291
-
- T cells
-
DOI 10.1182/blood-2007-03-082578
-
Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25-T cells. Blood 110, 2537-2544 (2007 (Pubitemid 47523176)
-
(2007)
Blood
, vol.110
, Issue.7
, pp. 2537-2544
-
-
Yang, Z.-Z.1
Novak, A.J.2
Ziesmer, S.C.3
Witzig, T.E.4
Ansell, S.M.5
-
20
-
-
58149376998
-
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T regulatory cells
-
Ai, W. Z. et al. Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T regulatory cells. Int. J. Cancer 124, 239-244 (2009
-
(2009)
Int. J. Cancer
, vol.124
, pp. 239-244
-
-
Ai, W.Z.1
-
21
-
-
67650446560
-
Malignant B cells skew the balance of regulatory T cells and TH17 cells in B cell non-Hodgkins lymphoma
-
Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B cell non-Hodgkins lymphoma. Cancer Res. 69, 5522-5530 (2009
-
(2009)
Cancer Res
, vol.69
, pp. 5522-5530
-
-
Yang, Z.Z.1
Novak, A.J.2
Ziesmer, S.C.3
Witzig, T.E.4
Ansell, S.M.5
-
22
-
-
0032871425
-
Aberrant expression and reverse signalling of CD70 on malignant B cells
-
DOI 10.1046/j.1365-2141.1999.01573.x
-
Lens, S. M. A. et al. Aberrant expression and reverse signalling of CD70 on malignant B cells. Br. J. Haematol. 106, 491-503 (1999 (Pubitemid 29450677)
-
(1999)
British Journal of Haematology
, vol.106
, Issue.2
, pp. 491-503
-
-
Lens, S.M.A.1
Drillenburg, P.2
Den Drijver, B.F.A.3
Van Schijndel, G.4
Pals, S.T.5
Van Lier, R.A.W.6
Van Oers, M.H.J.7
-
23
-
-
33646422454
-
Intratumoral CD4+CD25+ regulatory T cell-mediated suppression of infiltrating CD4+ T cells in B cell non-Hodgkin lymphoma
-
Yang, Z. Z., Novak, A. J., Stenson, M. J., Witzig, T. E. & Ansell, S. M. Intratumoral CD4+CD25+ regulatory T cell-mediated suppression of infiltrating CD4+ T cells in B cell non-Hodgkin lymphoma. Blood 107, 3639-3646 (2006
-
(2006)
Blood
, vol.107
, pp. 3639-3646
-
-
Yang, Z.Z.1
Novak, A.J.2
Stenson, M.J.3
Witzig, T.E.4
Ansell, S.M.5
-
24
-
-
84858626097
-
Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2 dependent recruitment and polarization of monocytes
-
Guilloton, F. et al. Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2 dependent recruitment and polarization of monocytes. Blood 119, 2556-2567 (2012
-
(2012)
Blood
, vol.119
, pp. 2556-2567
-
-
Guilloton, F.1
-
25
-
-
1842413105
-
The non-hodgkins lymphoma classification project A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkins lymphoma
-
The Non-Hodgkins Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkins lymphoma. Blood 89, 3909-3918 (1997
-
(1997)
Blood
, vol.89
, pp. 3909-3918
-
-
-
26
-
-
0036110314
-
The stromal composition of malignant lymphoid aggregates in bone marrow: Variations in architecture and phenotype in different B-cell tumours
-
DOI 10.1046/j.1365-2141.2002.03497.x
-
Vega, F. et al. The stromal composition of malignant lymphoid aggregates in bone marrow: Variations in architecture and phenotype in different B cell tumours. Br. J. Haematol. 117, 569-576 (2002 (Pubitemid 34539230)
-
(2002)
British Journal of Haematology
, vol.117
, Issue.3
, pp. 569-576
-
-
Vega, F.1
Medeiros, L.J.2
Lang, W.-H.3
Mansoor, A.4
Bueso-Ramos, C.5
Jones, D.6
-
27
-
-
84860347823
-
Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma
-
Rajnai, H. et al. Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma. Histopathology 60, E66-E75 (2012
-
(2012)
Histopathology
, vol.60
-
-
Rajnai, H.1
-
28
-
-
0035999150
-
Chronic B cell malignancies and bone marrow microenvironment
-
DOI 10.1006/scbi.2001.0423
-
Ghia, P., Granziero, L., Chilosi, M. & Caligaris-Cappio, F. Chronic B cell malignancies and bone marrow microenvironment. Semin. Cancer Biol. 12, 149-155 (2002 (Pubitemid 34680744)
-
(2002)
Seminars in Cancer Biology
, vol.12
, Issue.2
, pp. 149-155
-
-
Ghia, P.1
Granziero, L.2
Chilosi, M.3
Caligaris-Cappio, F.4
-
29
-
-
57749171165
-
The biology of Hodgkins lymphoma
-
Küppers, R. The biology of Hodgkins lymphoma. Nature Rev. Cancer 9, 15-27 (2008
-
(2008)
Nature Rev. Cancer
, vol.9
, pp. 15-27
-
-
Küppers, R.1
-
30
-
-
0023191121
-
The presence of clonogenic cells in high-grade malignant lymphoma: A prognostic factor
-
Tweeddale, M. E. et al. The presence of clonogenic cells in high-grade malignant lymphoma: A prognostic factor. Blood 69, 1307-1314 (1987 (Pubitemid 17085284)
-
(1987)
Blood
, vol.69
, Issue.5
, pp. 1307-1314
-
-
Tweeddale, M.E.1
Lim, B.2
Jamal, N.3
-
31
-
-
0027170870
-
The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori
-
DOI 10.1016/0140-6736(93)91408-E
-
Hussell, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J. The response of cells from low-grade B cell gastric lymphomas of mucosa-Associated lymphoid tissue to Helicobacter pylori. Lancet 342, 571-574 (1993 (Pubitemid 23259232)
-
(1993)
Lancet
, vol.342
, Issue.8871
, pp. 571-574
-
-
Hussell, T.1
Isaacson, P.G.2
Crabtree, J.E.3
Spencer, J.4
-
33
-
-
0025217133
-
+ T cell clones
-
Umetsu, D. T., Esserman, L., Donlon, T. A., DeKruyff, R. H. & Levy, R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J. Immunol. 144, 2550-2557 (1990 (Pubitemid 20136656)
-
(1990)
Journal of Immunology
, vol.144
, Issue.7
, pp. 2550-2557
-
-
Umetsu, D.T.1
Esserman, L.2
Donlon, T.A.3
Dekruyff, R.H.4
Levy, R.5
-
34
-
-
0027292644
-
Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system
-
Johnson, P. W. M. et al. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82, 1848-1857 (1993 (Pubitemid 23278776)
-
(1993)
Blood
, vol.82
, Issue.6
, pp. 1848-1857
-
-
Johnson, P.W.M.1
Watt, S.M.2
Betts, D.R.3
Davies, D.4
Jordan, S.5
Norton, A.J.6
Lister, T.A.7
-
35
-
-
0342711256
-
In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
-
DOI 10.1016/S0092-8674(00)80373-6
-
Lam, K. P., Kn, R. & Rajewsky, K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083 (1997 (Pubitemid 27408521)
-
(1997)
Cell
, vol.90
, Issue.6
, pp. 1073-1083
-
-
Lam, K.-P.1
Kuhn, R.2
Rajewsky, K.3
-
36
-
-
2942582913
-
Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer
-
DOI 10.1016/j.cell.2004.05.014, PII S0092867404005306
-
Kraus, M., Alimzhanov, M. B., Rajewsky, N. & Rajewsky, K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117, 787-800 (2004 (Pubitemid 38748894)
-
(2004)
Cell
, vol.117
, Issue.6
, pp. 787-800
-
-
Kraus, M.1
Alimzhanov, M.B.2
Rajewsky, N.3
Rajewsky, K.4
-
37
-
-
70350304558
-
PI3 kinase signals BCR-dependent mature B cell survival
-
Srinivasan, L. et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139, 573-586 (2009
-
(2009)
Cell
, vol.139
, pp. 573-586
-
-
Srinivasan, L.1
-
38
-
-
16844381831
-
Mechanisms of B cell lymphoma pathogenesis
-
Küppers, R. Mechanisms of B cell lymphoma pathogenesis. Nature Rev. Cancer 5, 251-262 (2005
-
(2005)
Nature Rev. Cancer
, vol.5
, pp. 251-262
-
-
Küppers, R.1
-
39
-
-
0021792138
-
Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype
-
Raffeld, M., Neckers, L., Longo, D. L. & Cossman, J. Spontaneous alteration of idiotype in a monoclonal B cell lymphoma-escape from detection by anti-idiotype. N. Engl. J. Med. 312, 1653-1658 (1985 (Pubitemid 15068571)
-
(1985)
New England Journal of Medicine
, vol.312
, Issue.26
, pp. 1653-1658
-
-
Raffeld, M.1
Neckers, L.2
Longo, D.L.3
Cossman, J.4
-
40
-
-
0021792139
-
Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies
-
Meeker, T. et al. Emergence of idiotype variants during treatment of B cell lymphoma with anti-idiotype antibodies. N. Engl. J. Med. 312, 1658-1665 (1985 (Pubitemid 15068572)
-
(1985)
New England Journal of Medicine
, vol.312
, Issue.26
, pp. 1658-1665
-
-
Meeker, T.1
Lowder, J.2
Cleary, M.L.3
-
41
-
-
84869752792
-
Self-Antigen recognition by follicular lymphoma B cell receptors
-
Sachen, K. L. et al. Self-Antigen recognition by follicular lymphoma B cell receptors. Blood 120, 4182-4190 (2012
-
(2012)
Blood
, vol.120
, pp. 4182-4190
-
-
Sachen, K.L.1
-
42
-
-
84876798571
-
Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen
-
Cha, S. C. et al. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J. Immunol. 190, 4887-4898 (2013
-
(2013)
J. Immunol
, vol.190
, pp. 4887-4898
-
-
Cha, S.C.1
-
43
-
-
77449108587
-
Gastric MALT lymphoma B cell express polyreactive, somatically mutated immunoglobulins
-
Craig, V. J. et al. Gastric MALT lymphoma B cell express polyreactive, somatically mutated immunoglobulins. Blood 115, 581-591 (2010
-
(2010)
Blood
, vol.115
, pp. 581-591
-
-
Craig, V.J.1
-
44
-
-
18244385722
-
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
-
DOI 10.1084/jem.20050068
-
Bende, R. J. et al. Among B cell non-Hodgkins lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J. Exp. Med. 201, 1229-1241 (2005 (Pubitemid 40629067)
-
(2005)
Journal of Experimental Medicine
, vol.201
, Issue.8
, pp. 1229-1241
-
-
Bende, R.J.1
Aarts, W.M.2
Riedl, R.G.3
De Jong, D.4
Pals, S.T.5
Van Noesel, C.J.M.6
-
45
-
-
80052929598
-
Is there a role for antigen selection in mantle cell lymphoma?. Immunogenetic support from a series of 807 cases
-
Hadzidimitriou, A. et al. Is there a role for antigen selection in mantle cell lymphoma?. Immunogenetic support from a series of 807 cases. Blood 118, 3088-3095 (2011
-
(2011)
Blood
, vol.118
, pp. 3088-3095
-
-
Hadzidimitriou, A.1
-
46
-
-
0036530010
-
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma
-
DOI 10.1182/blood.V99.7.2562
-
Zhu, D. et al. Acquisition of potential N glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99, 2562-2568 (2002 (Pubitemid 34525446)
-
(2002)
Blood
, vol.99
, Issue.7
, pp. 2562-2568
-
-
Zhu, D.1
McCarthy, H.2
Ottensmeier, C.H.3
Johnson, P.4
Hamblin, T.J.5
Stevenson, F.K.6
-
47
-
-
78649840358
-
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins
-
Coelho, V. et al. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc. Natl Acad. Sci. USA 107, 18587-18592 (2010
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, pp. 18587-18592
-
-
Coelho, V.1
-
48
-
-
38949143338
-
Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma
-
DOI 10.1016/j.molimm.2007.10.009, PII S0161589007008036
-
McCann, K. J. et al. Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Mol. Immunol. 45, 1567-1572 (2008 (Pubitemid 351221145)
-
(2008)
Molecular Immunology
, vol.45
, Issue.6
, pp. 1567-1572
-
-
McCann, K.J.1
Ottensmeier, C.H.2
Callard, A.3
Radcliffe, C.M.4
Harvey, D.J.5
Dwek, R.A.6
Rudd, P.M.7
Sutton, B.J.8
Hobby, P.9
Stevenson, F.K.10
-
49
-
-
80053449635
-
Early steps of follicular lymphoma pathogenesis
-
Roulland, S. et al. Early steps of follicular lymphoma pathogenesis. Adv. Immunol. 111, 1-46 (2011
-
(2011)
Adv. Immunol
, vol.111
, pp. 1-46
-
-
Roulland, S.1
-
50
-
-
84860346868
-
Follicular lymphoma and the immune system: From pathogenesis to antibody therapy
-
Stevenson, F. K. & Stevenson, G. T. Follicular lymphoma and the immune system: From pathogenesis to antibody therapy. Blood 119, 3659-3667 (2012
-
(2012)
Blood
, vol.119
, pp. 3659-3667
-
-
Stevenson, F.K.1
Stevenson, G.T.2
-
52
-
-
73849145729
-
Chronic active B cell-receptor signalling in diffuse large B cell lymphoma
-
Davis, R. E. et al. Chronic active B cell-receptor signalling in diffuse large B cell lymphoma. Nature 463, 88-92 (2010
-
(2010)
Nature
, vol.463
, pp. 88-92
-
-
Davis, R.E.1
-
53
-
-
41149136296
-
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
-
DOI 10.1126/science.1153629
-
Lenz, G. et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679 (2008 (Pubitemid 351432507)
-
(2008)
Science
, vol.319
, Issue.5870
, pp. 1676-1679
-
-
Lenz, G.1
Davis, R.E.2
Ngo, V.N.3
Lam, L.4
George, T.C.5
Wright, G.W.6
Dave, S.S.7
Zhao, H.8
Xu, W.9
Rosenwald, A.10
Ott, G.11
Muller-Hermelink, H.K.12
Gascoyne, R.D.13
Connors, J.M.14
Rimsza, L.M.15
Campo, E.16
Jaffe, E.S.17
Delabie, J.18
Smeland, E.B.19
Fisher, R.I.20
Chan, W.C.21
Staudt, L.M.22
more..
-
54
-
-
79551686422
-
Oncogenically active MYD88 mutations in human lymphoma
-
Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119 (2010
-
(2010)
Nature
, vol.470
, pp. 115-119
-
-
Ngo, V.N.1
-
55
-
-
84866429139
-
The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development
-
Rossi, D. et al. The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development. J. Exp. Med. 209, 1537-1551 (2012
-
(2012)
J. Exp. Med
, vol.209
, pp. 1537-1551
-
-
Rossi, D.1
-
56
-
-
84859450196
-
BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas
-
Yan, Q. et al. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica 97, 595-598 (2012
-
(2012)
Haematologica
, vol.97
, pp. 595-598
-
-
Yan, Q.1
-
57
-
-
84865475885
-
MYD88 L265P somatic mutation in Waldenstroms macroglobulinemia
-
Treon, S. P. et al. MYD88 L265P somatic mutation in Waldenstroms macroglobulinemia. N. Engl. J. Med. 367, 826-833 (2012
-
(2012)
N. Engl. J. Med
, vol.367
, pp. 826-833
-
-
Treon, S.P.1
-
58
-
-
84896814479
-
Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance
-
Wang, J. Q., Jeelall, Y. S., Beutler, B., Horikawa, K. & Goodnow, C. C. Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance. J. Exp. Med. 211, 413-426 (2014
-
(2014)
J. Exp. Med
, vol.211
, pp. 413-426
-
-
Wang, J.Q.1
Jeelall, Y.S.2
Beutler, B.3
Horikawa, K.4
Goodnow, C.C.5
-
59
-
-
78650309840
-
Follicular lymphoma cell niche: Identification of a preeminent IL 4 dependent TFH B cell axis
-
Pangault, C. et al. Follicular lymphoma cell niche: Identification of a preeminent IL 4 dependent TFH B cell axis. Leukemia 24, 2080-2089 (2010
-
(2010)
Leukemia
, vol.24
, pp. 2080-2089
-
-
Pangault, C.1
-
60
-
-
55749114922
-
IL 4 protein expression and basal activation of Erk in vivo in follicular lymphoma
-
Calvo, K. R. et al. IL 4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 112, 3818-3826 (2008
-
(2008)
Blood
, vol.112
, pp. 3818-3826
-
-
Calvo, K.R.1
-
61
-
-
84856708321
-
Monocytes and T cells cooperate to favor normal and follicular lymphoma B cell growth: Role of IL 15 and CD40L signaling
-
Epron, G. et al. Monocytes and T cells cooperate to favor normal and follicular lymphoma B cell growth: Role of IL 15 and CD40L signaling. Leukemia 26, 139-148 (2012
-
(2012)
Leukemia
, vol.26
, pp. 139-148
-
-
Epron, G.1
-
62
-
-
0035860559
-
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
-
DOI 10.1126/science.1061964
-
Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114 (2001 (Pubitemid 32848063)
-
(2001)
Science
, vol.293
, Issue.5537
, pp. 2111-2114
-
-
Schiemann, B.1
Gommerman, J.L.2
Vora, K.3
Cachero, T.G.4
Shutga-Morskaya, S.5
Dobles, M.6
Frew, E.7
Scott, M.L.8
-
63
-
-
41949138741
-
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
-
Belnoue, E. et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 111, 2755-2764 (2008
-
(2008)
Blood
, vol.111
, pp. 2755-2764
-
-
Belnoue, E.1
-
64
-
-
79959196668
-
Tumor-Associated macrophages as major source of APRIL in gastric MALT lymphoma
-
Munari, F. et al. Tumor-Associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood 117, 6612-6616 (2011
-
(2011)
Blood
, vol.117
, pp. 6612-6616
-
-
Munari, F.1
-
65
-
-
34249709065
-
Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease [11]
-
DOI 10.1038/sj.leu.2404627, PII 2404627
-
Schwaller, J. et al. Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkins disease. Leukemia 21, 1324-1327 (2007 (Pubitemid 46831829)
-
(2007)
Leukemia
, vol.21
, Issue.6
, pp. 1324-1327
-
-
Schwaller, J.1
Went, P.2
Matthes, T.3
Dirnhofer, S.4
Donze, O.5
Mhawech-Fauceglia, P.6
Myit, S.7
Huard, B.8
-
66
-
-
33845969135
-
Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness
-
DOI 10.1182/blood-2006-02-001800
-
Schwaller, J. et al. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B cell lymphoma aggressiveness. Blood 109, 331-338 (2007 (Pubitemid 46053074)
-
(2007)
Blood
, vol.109
, Issue.1
, pp. 331-338
-
-
Schwaller, J.1
Schneider, P.2
Mhawech-Fauceglia, P.3
McKee, T.4
Myit, S.5
Matthes, T.6
Tschopp, J.7
Donze, O.8
Le Gal, F.-A.9
Huard, B.10
-
67
-
-
14044259331
-
Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: Implications for Burkitt's lymphoma
-
Ogden, C. A. et al. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL 10 activated macrophages: Implications for Burkitts lymphoma. J. Immunol. 174, 3015-3023 (2005 (Pubitemid 40279722)
-
(2005)
Journal of Immunology
, vol.174
, Issue.5
, pp. 3015-3023
-
-
Ogden, C.A.1
Pound, J.D.2
Batth, B.K.3
Owens, S.4
Johannessen, I.5
Wood, K.6
Gregory, C.D.7
-
68
-
-
0030657010
-
In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand
-
Buske, C. et al. In vitro activation of low-grade non-Hodgkins lymphoma by murine fibroblasts, IL 4, anti CD40 antibodies and the soluble CD40 ligand. Leukemia 11, 1862-1867 (1997 (Pubitemid 27485131)
-
(1997)
Leukemia
, vol.11
, Issue.11
, pp. 1862-1867
-
-
Buske, C.1
Twiling, A.2
Gogowski, G.3
Schreiber, K.4
Feuring-Buske, M.5
Wulf, C.G.6
Hiddemann, W.7
Wormann, B.8
-
69
-
-
58249102301
-
Lymphoma cell adhesion-induced expression of B cell-Activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkins B lymphoma cells from apoptosis
-
Lwin, T. et al. Lymphoma cell adhesion-induced expression of B cell-Activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkins B lymphoma cells from apoptosis. Leukemia 23, 170-177 (2009
-
(2009)
Leukemia
, vol.23
, pp. 170-177
-
-
Lwin, T.1
-
70
-
-
33846255324
-
Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B cell growth: Role of stromal cells in follicular lymphoma pathogenesis
-
Am-Thomas, P. et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B cell growth: Role of stromal cells in follicular lymphoma pathogenesis. Blood 109, 693-702 (2007
-
(2007)
Blood
, vol.109
, pp. 693-702
-
-
Am-Thomas, P.1
-
71
-
-
84864779051
-
Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B cell activating factor and activation of the canonical and non-canonical nuclear factor κb pathways
-
Medina, D. J. et al. Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways. Haematologica 97, 1255-1263 (2012
-
(2012)
Haematologica
, vol.97
, pp. 1255-1263
-
-
Medina, D.J.1
-
72
-
-
34547683699
-
Essential role of stromally induced hedgehog signaling in B-cell malignancies
-
DOI 10.1038/nm1614, PII NM1614
-
Dierks, C. et al. Essential role of stromally induced hedgehog signaling in B cell malignancies. Nature Med. 13, 944-951 (2007 (Pubitemid 47222041)
-
(2007)
Nature Medicine
, vol.13
, Issue.8
, pp. 944-951
-
-
Dierks, C.1
Grbic, J.2
Zirlik, K.3
Beigi, R.4
Englund, N.P.5
Guo, G.-R.6
Veelken, H.7
Engelhardt, M.8
Mertelsmann, R.9
Kelleher, J.F.10
Schultz, P.11
Warmuth, M.12
-
73
-
-
77952420404
-
Hedgehog signaling pathway is activated in diffuse large B cell lymphoma and contributes to tumor cell survival and proliferation
-
Singh, R. R. et al. Hedgehog signaling pathway is activated in diffuse large B cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 24, 1025-1036 (2010
-
(2010)
Leukemia
, vol.24
, pp. 1025-1036
-
-
Singh, R.R.1
-
74
-
-
70349694160
-
Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B cell lymphoma
-
Kim, J. E. et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B cell lymphoma. Mod. Pathol. 22, 1312-1320 (2009
-
(2009)
Mod. Pathol
, vol.22
, pp. 1312-1320
-
-
Kim, J.E.1
-
75
-
-
0034669309
-
Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B cell lymphomas arising in immune-privileged sites
-
Riemersma, S. A. et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B cell lymphomas arising in immune-privileged sites. Blood 96, 3569-3577 (2000
-
(2000)
Blood
, vol.96
, pp. 3569-3577
-
-
Riemersma, S.A.1
-
76
-
-
79952816655
-
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
-
Steidl, C. et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471, 377-381 (2011
-
(2011)
Nature
, vol.471
, pp. 377-381
-
-
Steidl, C.1
-
77
-
-
84856882081
-
Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B cell lymphoma
-
Wilkinson, S. T. et al. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B cell lymphoma. Blood 119, 1459-1467 (2011
-
(2011)
Blood
, vol.119
, pp. 1459-1467
-
-
Wilkinson, S.T.1
-
78
-
-
2542429298
-
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
-
DOI 10.1182/blood-2003-07-2365
-
Rimsza, L. M. et al. Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103, 4251-4258 (2004 (Pubitemid 38685371)
-
(2004)
Blood
, vol.103
, Issue.11
, pp. 4251-4258
-
-
Rimsza, L.M.1
Roberts, R.A.2
Miller, T.P.3
Unger, J.M.4
Leblanc, M.5
Braziel, R.M.6
Weisenberger, D.D.7
Chan, W.C.8
Muller-Hermelink, H.K.9
Jaffe, E.S.10
Gascoyne, R.D.11
Campo, E.12
Fuchs, D.A.13
Spier, C.M.14
Fisher, R.I.15
Delabie, J.16
Rosenwald, A.17
Staudt, L.M.18
Grogan, T.M.19
-
79
-
-
83555173561
-
Combined genetic inactivation of β2 Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma
-
Challa-Malladi, M. et al. Combined genetic inactivation of β2 Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20, 728-740 (2011
-
(2011)
Cancer Cell
, vol.20
, pp. 728-740
-
-
Challa-Malladi, M.1
-
80
-
-
80052269038
-
Analysis of the coding genome of diffuse large B cell lymphoma
-
Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B cell lymphoma. Nature Genet. 43, 830-837 (2011
-
(2011)
Nature Genet
, vol.43
, pp. 830-837
-
-
Pasqualucci, L.1
-
81
-
-
80052029516
-
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
-
Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298-303 (2011
-
(2011)
Nature
, vol.476
, pp. 298-303
-
-
Morin, R.D.1
-
82
-
-
0141672946
-
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
-
DOI 10.1084/jem.20031074
-
Rosenwald, A. et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med. 198, 851-862 (2003 (Pubitemid 37152922)
-
(2003)
Journal of Experimental Medicine
, vol.198
, Issue.6
, pp. 851-862
-
-
Rosenwald, A.1
Wright, G.2
Leroy, K.3
Yu, X.4
Gaulard, P.5
Gascoyne, R.D.6
Chan, W.C.7
Zhao, T.8
Haioun, C.9
Greiner, T.C.10
Weisenburger, D.D.11
Lynch, J.C.12
Vose, J.13
Armitage, J.O.14
Smeland, E.B.15
Kvaloy, S.16
Holte, H.17
Delabie, J.18
Campo, E.19
Montserrat, E.20
Lopez-Guillermo, A.21
Ott, G.22
Muller-Hermelink, H.K.23
Connors, J.M.24
Braziel, R.25
Grogan, T.M.26
Fisher, R.I.27
Miller, T.P.28
Leblanc, M.29
Chiorazzi, M.30
Zhao, H.31
Yang, L.32
Powell, J.33
Wilson, W.H.34
Jaffe, E.S.35
Simon, R.36
Klausner, R.D.37
Staudt, L.M.38
more..
-
83
-
-
78049370405
-
Integrative analysis reveals selective 9p24.1 amplification, increased PD 1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B cell lymphoma
-
Green, M. R. et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD 1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B cell lymphoma. Blood 116, 3268-3277 (2010
-
(2010)
Blood
, vol.116
, pp. 3268-3277
-
-
Green, M.R.1
-
84
-
-
77955866440
-
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
-
Steidl, C. et al. Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome. Blood 116, 418-427 (2010
-
(2010)
Blood
, vol.116
, pp. 418-427
-
-
Steidl, C.1
-
85
-
-
38849095307
-
HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma
-
DOI 10.1111/j.1399-0039.2008.01005.x
-
Diepstra, A. et al. HLA G protein expression as a potential immune escape mechanism in classical Hodgkins lymphoma. Tissue Antigens 71, 219-226 (2008 (Pubitemid 351197075)
-
(2008)
Tissue Antigens
, vol.71
, Issue.3
, pp. 219-226
-
-
Diepstra, A.1
Poppema, S.2
Boot, M.3
Visser, L.4
Nolte, I.M.5
Niens, M.6
Te Meerman, G.J.7
Van Den Berg, A.8
-
86
-
-
0035117646
-
Fas ligand expression in Hodgkin lymphoma
-
DOI 10.1097/00000478-200103000-00014
-
Verbeke, C. S., Wenthe, U., Grobholz, R. & Zentgraf, H. Fas ligand expression in Hodgkin lymphoma. Am. J. Surg. Pathol. 25, 388-394 (2001 (Pubitemid 32174208)
-
(2001)
American Journal of Surgical Pathology
, vol.25
, Issue.3
, pp. 388-394
-
-
Verbeke, C.S.1
Wenthe, U.2
Grobholz, R.3
Zentgraf, H.4
-
87
-
-
73949116990
-
Follicular lymphoma cell induce T cell immunologic synapse dysfunction that can be repaired with lenalidomide: Implications for the tumor microenvironment and immunotherapy
-
Ramsay, A. G. et al. Follicular lymphoma cell induce T cell immunologic synapse dysfunction that can be repaired with lenalidomide: Implications for the tumor microenvironment and immunotherapy. Blood 114, 4713-4720 (2009
-
(2009)
Blood
, vol.114
, pp. 4713-4720
-
-
Ramsay, A.G.1
-
88
-
-
84890531605
-
Follicular lymphoma cells induce changes in T cell gene expression and function: Potential impact on survival and risk of transformation
-
Kiaii, S. et al. Follicular lymphoma cells induce changes in T cell gene expression and function: Potential impact on survival and risk of transformation. J. Clin. Oncol. 31, 2654-2661 (2013
-
(2013)
J. Clin. Oncol
, vol.31
, pp. 2654-2661
-
-
Kiaii, S.1
-
89
-
-
33750535641
-
+ regulatory T cells in B-cell non-Hodgkin's lymphoma
-
DOI 10.1158/0008-5472.CAN-06-1822
-
Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M. Attenuation of CD8+ T cell function by CD4+CD25+ regulatory T cells in B cell non-Hodgkins lymphoma. Cancer Res. 66, 10145-10152 (2006 (Pubitemid 44672069)
-
(2006)
Cancer Research
, vol.66
, Issue.20
, pp. 10145-10152
-
-
Yang, Z.-Z.1
Novak, A.J.2
Ziesmer, S.C.3
Witzig, T.E.4
Ansell, S.M.5
-
90
-
-
84860747727
-
Characterization of intratumoral follicular helper T cells in follicular lymphoma: Role in the survival of malignant B cells
-
Amé-Thomas, P. et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: Role in the survival of malignant B cells. Leukemia 26, 1053-1063 (2012
-
(2012)
Leukemia
, vol.26
, pp. 1053-1063
-
-
Amé-Thomas, P.1
-
91
-
-
77950950894
-
Macrophage diversity enhances tumor progression and metastasis
-
Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51 (2010
-
(2010)
Cell
, vol.141
, pp. 39-51
-
-
Qian, B.Z.1
Pollard, J.W.2
-
92
-
-
33745938078
-
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
-
DOI 10.1182/blood-2005-12-5125
-
Sánchez-Aguilera, A. et al. Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma. Blood 108, 662-668 (2006 (Pubitemid 44061368)
-
(2006)
Blood
, vol.108
, Issue.2
, pp. 662-668
-
-
Sanchez-Aguilera, A.1
Montalban, C.2
De La Cueva, P.3
Sanchez-Verde, L.4
Morente, M.M.5
Garcia-Cosio, M.6
Garcia-Larana, J.7
Bellas, C.8
Provencio, M.9
Romagosa, V.10
Fernandez De Sevilla, A.11
Menarguez, J.12
Sabin, P.13
Mestre, M.J.14
Mendez, M.15
Fresno, M.F.16
Nicolas, C.17
Piris, M.A.18
Garcia, J.F.19
-
93
-
-
63849185609
-
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
-
Chetaille, B. et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113, 2765-2775 (2009
-
(2009)
Blood
, vol.113
, pp. 2765-2775
-
-
Chetaille, B.1
-
94
-
-
77949345555
-
Tumor-Associated macrophages and survival in classic Hodgkins lymphoma
-
Steidl, C. et al. Tumor-Associated macrophages and survival in classic Hodgkins lymphoma. N. Engl. J. Med. 362, 875-885 (2010
-
(2010)
N. Engl. J. Med
, vol.362
, pp. 875-885
-
-
Steidl, C.1
-
95
-
-
57149089307
-
Stromal gene signatures in large B cell lymphomas
-
Lenz, G. et al. Stromal gene signatures in large B cell lymphomas. N. Engl. J. Med. 359, 2313-2323 (2008
-
(2008)
N. Engl. J. Med
, vol.359
, pp. 2313-2323
-
-
Lenz, G.1
-
96
-
-
8644252736
-
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
-
DOI 10.1056/NEJMoa041869
-
Dave, S. S. et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 351, 2159-2169 (2004 (Pubitemid 39507628)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.21
, pp. 2159-2169
-
-
Dave, S.S.1
Wright, G.2
Tan, B.3
Rosenwald, A.4
Gascoyne, R.D.5
Chan, W.C.6
Fisher, R.I.7
Braziel, R.M.8
Rimsza, L.M.9
Grogan, T.M.10
Miller, T.P.11
Leblanc, M.12
Greiner, T.C.13
Weisenburger, D.D.14
Lynch, J.C.15
Vose, J.16
Armitage, J.O.17
Smeland, E.B.18
Kvaloy, S.19
Holte, H.20
Delabie, J.21
Connors, J.M.22
Lansdorp, P.M.23
Ouyang, Q.24
Lister, T.A.25
Davies, A.J.26
Norton, A.J.27
Muller-Hermelink, H.K.28
Ott, G.29
Campo, E.30
Montserrat, E.31
Wilson, W.H.32
Jaffe, E.S.33
Simon, R.34
Yang, L.35
Powell, J.36
Zhao, H.37
Goldschmidt, N.38
Chiorazzi, M.39
Staudt, L.M.40
more..
-
97
-
-
20044367117
-
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
-
DOI 10.1158/1078-0432.CCR-04-1869
-
Álvaro, T. et al. Outcome in Hodgkins lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin. Cancer Res. 11, 1467-1473 (2005 (Pubitemid 40315228)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.4
, pp. 1467-1473
-
-
Alvaro, T.1
Lejeune, M.2
Salvado, Ma.T.3
Bosch, R.4
Garcia, J.F.5
Jaen, J.6
Banham, A.H.7
Roncador, G.8
Montalban, C.9
Piris, M.A.10
-
98
-
-
38049022492
-
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl 2 and MAL expression
-
Kelley, T. W., Pohlman, B., Elson, P. & Hsi, E. D. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl 2 and MAL expression. Am. J. Clin. Pathol. 128, 958-965 (2007
-
(2007)
Am. J. Clin. Pathol
, vol.128
, pp. 958-965
-
-
Kelley, T.W.1
Pohlman, B.2
Elson, P.3
Hsi, E.D.4
-
99
-
-
0036187615
-
The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies
-
DOI 10.1002/path.1027
-
Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-Associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 196, 254-265 (2002 (Pubitemid 34189413)
-
(2002)
Journal of Pathology
, vol.196
, Issue.3
, pp. 254-265
-
-
Bingle, L.1
Brown, N.J.2
Lewis, C.E.3
-
100
-
-
84858800620
-
The immune contexture in human tumours: Impact on clinical outcome
-
Fridman, W. H., Pagès, F., Sautès-Fridman, C. & Galon, J. The immune contexture in human tumours: Impact on clinical outcome. Nature Rev. Cancer 12, 298-306 (2012
-
(2012)
Nature Rev. Cancer
, vol.12
, pp. 298-306
-
-
Fridman, W.H.1
Pagès, F.2
Sautès-Fridman, C.3
Galon, J.4
-
101
-
-
77956544224
-
A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma
-
Sánchez-Espiridión, B. et al. A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma. Blood 116, e12-e17 (2010
-
(2010)
Blood
, vol.116
-
-
Sánchez-Espiridión, B.1
-
102
-
-
84875743842
-
Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma
-
Scott, D. W. et al. Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J. Clin. Oncol. 31, 692-700 (2013
-
(2013)
J. Clin. Oncol
, vol.31
, pp. 692-700
-
-
Scott, D.W.1
-
103
-
-
79251502962
-
The stromal cell marker SPARC predicts for survival in patients with diffuse large B cell lymphoma treated with rituximab
-
Meyer, P. N. et al. The stromal cell marker SPARC predicts for survival in patients with diffuse large B cell lymphoma treated with rituximab. Am. J. Clin. Pathol. 135, 54-61 (2011
-
(2011)
Am. J. Clin. Pathol
, vol.135
, pp. 54-61
-
-
Meyer, P.N.1
-
104
-
-
79959944338
-
High microvessel density determines a poor outcome in patients with diffuse large B cell lymphoma treated with rituximab plus chemotherapy
-
Cardesa-Salzmann, T. M. et al. High microvessel density determines a poor outcome in patients with diffuse large B cell lymphoma treated with rituximab plus chemotherapy. Haematologica 96, 996-1001 (2011
-
(2011)
Haematologica
, vol.96
, pp. 996-1001
-
-
Cardesa-Salzmann, T.M.1
-
105
-
-
58149242769
-
Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
-
De Jong, D. et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 94, 70-77 (2009
-
(2009)
Haematologica
, vol.94
, pp. 70-77
-
-
De Jong, D.1
-
106
-
-
77955386082
-
Implications of the tumor microenvironment on survival and disease response in follicular lymphoma
-
Gribben, J. G. Implications of the tumor microenvironment on survival and disease response in follicular lymphoma. Curr. Opin. Oncol. 22, 424-430 (2010
-
(2010)
Curr. Opin. Oncol
, vol.22
, pp. 424-430
-
-
Gribben, J.G.1
-
107
-
-
84867148654
-
Pathogenesis of follicular lymphoma
-
Kridel, R., Sehn, L. H. & Gascoyne, R. D. Pathogenesis of follicular lymphoma. J. Clin. Invest. 122, 3424-3431 (2012
-
(2012)
J. Clin. Invest
, vol.122
, pp. 3424-3431
-
-
Kridel, R.1
Sehn, L.H.2
Gascoyne, R.D.3
-
108
-
-
84897402974
-
The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: A validation study from the Lunenburg Lymphoma Biomarker Consortium
-
Sander, B. et al. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: A validation study from the Lunenburg Lymphoma Biomarker Consortium. Haematologica 99, 715-725 (2014
-
(2014)
Haematologica
, vol.99
, pp. 715-725
-
-
Sander, B.1
-
109
-
-
34249981509
-
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival
-
DOI 10.1182/blood-2006-11-058040
-
Cerhan, J. R. et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 109, 5439-5446 (2007 (Pubitemid 46890567)
-
(2007)
Blood
, vol.109
, Issue.12
, pp. 5439-5446
-
-
Cerhan, J.R.1
Wang, S.2
Maurer, M.J.3
Ansell, S.M.4
Geyer, S.M.5
Cozen, W.6
Morton, L.M.7
Davis, S.8
Severson, R.K.9
Rothman, N.10
Lynch, C.F.11
Wacholder, S.12
Chanock, S.J.13
Habermann, T.M.14
Hartge, P.15
-
110
-
-
53449095327
-
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B cell lymphoma patients in the pre-rituximab era
-
Habermann, T. M. et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B cell lymphoma patients in the pre-rituximab era. Blood 112, 2694-2702 (2008
-
(2008)
Blood
, vol.112
, pp. 2694-2702
-
-
Habermann, T.M.1
-
111
-
-
84885189071
-
Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts
-
Ghesquieres, H. et al. Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: Results from two independent cohorts. Cytokine 64, 523-531 (2013
-
(2013)
Cytokine
, vol.64
, pp. 523-531
-
-
Ghesquieres, H.1
-
112
-
-
84875174768
-
The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities
-
McMillin, D. W., Negri, J. M. & Mitsiades, C. S. The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities. Nature Rev. Drug Discov. 12, 217-228 (2013
-
(2013)
Nature Rev. Drug Discov
, vol.12
, pp. 217-228
-
-
McMillin, D.W.1
Negri, J.M.2
Mitsiades, C.S.3
-
113
-
-
34250788040
-
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin's lymphoma cells
-
DOI 10.1038/sj.leu.2404723, PII 2404723
-
Lwin, T. et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-Apoptotic proteins associated with activation of NF κB (RelB/p52) in non-Hodgkins lymphoma cells. Leukemia 21, 1521-1531 (2007 (Pubitemid 46965295)
-
(2007)
Leukemia
, vol.21
, Issue.7
, pp. 1521-1531
-
-
Lwin, T.1
Hazlehurst, L.A.2
Li, Z.3
Dessureault, S.4
Sotomayor, E.5
Moscinski, L.C.6
Dalton, W.S.7
Tao, J.8
-
114
-
-
66549113998
-
Mantle cell lymphoma cells express high levels of CXCR4
-
Kurtova, A. V., Tamayo, A. T., Ford, R. J. & Burger, J. A. Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA (CD49d): Importance for interactions with the stromal microenvironment and specific targeting. Blood 113, 4604-4613 (2009
-
(2009)
CXCR5, and VLA (CD49d): Importance for Interactions with the Stromal Microenvironment and Specific Targeting. Blood
, vol.113
, pp. 4604-4613
-
-
Kurtova, A.V.1
Tamayo, A.T.2
Ford, R.J.3
Burger, J.A.4
-
115
-
-
80052570271
-
Bone marrow stromal cells protect lymphoma B cells from rituximab-induced apoptosis and targeting integrin α-4 β-1 (VLA 4) with natalizumab can overcome this resistance
-
Mraz, M. et al. Bone marrow stromal cells protect lymphoma B cells from rituximab-induced apoptosis and targeting integrin α-4 β-1 (VLA 4) with natalizumab can overcome this resistance. Br. J. Haematol. 155, 53-64 (2011
-
(2011)
Br. J. Haematol
, vol.155
, pp. 53-64
-
-
Mraz, M.1
-
116
-
-
78650056617
-
Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA 181a
-
Lwin, T. et al. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA 181a. Blood 116, 5228-5236 (2010
-
(2010)
Blood
, vol.116
, pp. 5228-5236
-
-
Lwin, T.1
-
117
-
-
84887421655
-
A microenvironment-mediated c Myc/ miR 548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
-
Lwin, T. et al. A microenvironment-mediated c Myc/ miR 548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas. J. Clin. Invest. 123, 4612-4626 (2013
-
(2013)
J. Clin. Invest
, vol.123
, pp. 4612-4626
-
-
Lwin, T.1
-
118
-
-
34547137412
-
Skp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas
-
DOI 10.1182/blood-2006-11-060350
-
Lwin, T. et al. Cell adhesion induces p27Kip1 associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B cell lymphomas. Blood 110, 1631-1638 (2007 (Pubitemid 47443981)
-
(2007)
Blood
, vol.110
, Issue.5
, pp. 1631-1638
-
-
Lwin, T.1
Hazlehurst, L.A.2
Dessureault, S.3
Lai, R.4
Bai, W.5
Sotomayor, E.6
Moscinski, L.C.7
Dalton, W.S.8
Tao, J.9
-
119
-
-
0027213922
-
Regression of primary low-grade-B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
-
DOI 10.1016/0140-6736(93)91409-F
-
Wotherspoon, A. C. et al. Regression of primary low-grade B cell gastric lymphoma of mucosa-Associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342, 575-577 (1993 (Pubitemid 23259233)
-
(1993)
Lancet
, vol.342
, Issue.8871
, pp. 575-577
-
-
Wotherspoon, A.C.1
Doglioni, C.2
Diss, T.C.3
Pan, L.4
Moschini, A.5
De Boni, M.6
Isaacson, P.G.7
-
120
-
-
79955806814
-
Active and passive immunotherapy for lymphoma: Proving principles and improving results
-
Brody, J., Kohrt, H., Marabelle, A. & Levy, R. Active and passive immunotherapy for lymphoma: Proving principles and improving results. J. Clin. Oncol. 29, 1864-1875 (2011
-
(2011)
J. Clin. Oncol
, vol.29
, pp. 1864-1875
-
-
Brody, J.1
Kohrt, H.2
Marabelle, A.3
Levy, R.4
-
121
-
-
84867870598
-
Novel therapy for therapy-resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling
-
Hegde, G. V. et al. Novel therapy for therapy-resistant mantle cell lymphoma: Multipronged approach with targeting of hedgehog signaling. Int. J. Cancer 131, 2951-2960 (2012
-
(2012)
Int. J. Cancer
, vol.131
, pp. 2951-2960
-
-
Hegde, G.V.1
-
122
-
-
84871806385
-
Bruton tyrosine kinase inhibitor ibrutinib (PCI 32765) has significant activity in patients with relapsed/refractory B cell malignancies
-
Advani, R. H. et al. Bruton tyrosine kinase inhibitor ibrutinib (PCI 32765) has significant activity in patients with relapsed/refractory B cell malignancies. J. Clin. Oncol. 31, 88-94 (2013
-
(2013)
J. Clin. Oncol
, vol.31
, pp. 88-94
-
-
Advani, R.H.1
-
123
-
-
84893502903
-
Sensitizing protective tumor microenvironments to antibody-mediated therapy
-
Pallasch, C. P. et al. Sensitizing protective tumor microenvironments to antibody-mediated therapy. Cell 156, 590-602 (2014
-
(2014)
Cell
, vol.156
, pp. 590-602
-
-
Pallasch, C.P.1
-
124
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
125
-
-
84874613534
-
The role of angiogenesis in human non-Hodgkin lymphomas
-
Ribatti, D., Nico, B., Ranieri, G., Specchia, G. & Vacca, A. The role of angiogenesis in human non-Hodgkin lymphomas. Neoplasia 15, 231-238 (2013
-
(2013)
Neoplasia
, vol.15
, pp. 231-238
-
-
Ribatti, D.1
Nico, B.2
Ranieri, G.3
Specchia, G.4
Vacca, A.5
-
126
-
-
34247897170
-
Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
-
DOI 10.2353/ajpath.2007.060901
-
Gratzinger, D. et al. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B cell lymphoma subtypes. Am. J. Pathol. 170, 1362-1369 (2007 (Pubitemid 47339342)
-
(2007)
American Journal of Pathology
, vol.170
, Issue.4
, pp. 1362-1369
-
-
Gratzinger, D.1
Zhao, S.2
Marinelli, R.J.3
Kapp, A.V.4
Tibshirani, R.J.5
Hammer, A.S.6
Hamilton-Dutoit, S.7
Natkunam, Y.8
-
127
-
-
37549055122
-
Prognostic significance of VEGF VEGF receptors and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
-
Gratzinger, D. et al. Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest. 88, 38-47 (2008
-
(2008)
Lab Invest
, vol.88
, pp. 38-47
-
-
Gratzinger, D.1
-
128
-
-
72649103913
-
Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R CHOP
-
Gratzinger, D. et al. Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R CHOP). Br. J. Haematol. 148, 235-244 (2010
-
(2010)
Br. J. Haematol
, vol.148
, pp. 235-244
-
-
Gratzinger, D.1
-
129
-
-
84865168191
-
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B cell non-Hodgkin lymphoma: SWOG 0515
-
Stopeck, A. T. et al. A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B cell non-Hodgkin lymphoma: SWOG 0515. Blood 120, 1210-1217 (2012
-
(2012)
Blood
, vol.120
, pp. 1210-1217
-
-
Stopeck, A.T.1
-
130
-
-
84884170348
-
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
-
Ruan, J. et al. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood 121, 5192-5202 (2013
-
(2013)
Blood
, vol.121
, pp. 5192-5202
-
-
Ruan, J.1
-
131
-
-
84857478229
-
Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
-
OCallaghan, K. et al. Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia. Blood 119, 1717-1725 (2012
-
(2012)
Blood
, vol.119
, pp. 1717-1725
-
-
Ocallaghan, K.1
-
132
-
-
84855458019
-
Enhancement of the anti-Tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists
-
Hu, Y. et al. Enhancement of the anti-Tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists. Leuk. Lymphoma 53, 130-138 (2012
-
(2012)
Leuk. Lymphoma
, vol.53
, pp. 130-138
-
-
Hu, Y.1
-
133
-
-
84876477884
-
Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B cell receptor signaling
-
Burger, J. A. & Montserrat, E. Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B cell receptor signaling. Blood 121, 1501-1509 (2013
-
(2013)
Blood
, vol.121
, pp. 1501-1509
-
-
Burger, J.A.1
Montserrat, E.2
-
134
-
-
84881225049
-
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
-
Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507-516 (2013
-
(2013)
N. Engl. J. Med
, vol.369
, pp. 507-516
-
-
Wang, M.L.1
-
135
-
-
84887695622
-
Egress of CD19+CD5+ cells into the peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
-
Chang, B. Y. et al. Egress of CD19+CD5+ cells into the peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients. Blood 122, 2412-2424 (2013
-
(2013)
Blood
, vol.122
, pp. 2412-2424
-
-
Chang, B.Y.1
-
136
-
-
84895815322
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
-
Okosun, J. et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Nature Genet. 46, 176-181 (2013
-
(2013)
Nature Genet
, vol.46
, pp. 176-181
-
-
Okosun, J.1
-
137
-
-
84892553514
-
Genetics of follicular lymphoma transformation
-
Pasqualucci, L. et al. Genetics of follicular lymphoma transformation. Cell Rep. 6, 130-140 (2014
-
(2014)
Cell Rep
, vol.6
, pp. 130-140
-
-
Pasqualucci, L.1
-
138
-
-
0242551584
-
Homing and cellular traffic in lymph nodes
-
Von Andrian, U. H. & Mempel, T. R. Homing and cellular traffic in lymph nodes. Nature Rev. Immunol. 3, 867-878 (2003 (Pubitemid 37411716)
-
(2003)
Nature Reviews Immunology
, vol.3
, Issue.11
, pp. 867-878
-
-
Von Andrian, U.H.1
Mempel, T.R.2
-
139
-
-
70249085585
-
Stromal cell contributions to the homeostasis and functionality of the immune system
-
Mueller, S. N. & Germain, R. N. Stromal cell contributions to the homeostasis and functionality of the immune system. Nature Rev. Immunol. 9, 618-629 (2009
-
(2009)
Nature Rev. Immunol
, vol.9
, pp. 618-629
-
-
Mueller, S.N.1
Germain, R.N.2
-
140
-
-
58149097584
-
The who, how and where of antigen presentation to B cells
-
Batista, F. D. & Harwood, N. E. The who, how and where of antigen presentation to B cells. Nature Rev. Immunol. 9, 15-27 (2009
-
(2009)
Nature Rev. Immunol
, vol.9
, pp. 15-27
-
-
Batista, F.D.1
Harwood, N.E.2
-
141
-
-
84555173651
-
Molecular programming of B cell memory
-
McHeyzer-Williams, M., Okitsu, S., Wang, N. & McHeyzer-Williams, L. Molecular programming of B cell memory. Nature Rev. Immunol. 12, 24-34 (2012
-
(2012)
Nature Rev. Immunol
, vol.12
, pp. 24-34
-
-
McHeyzer-Williams, M.1
Okitsu, S.2
Wang, N.3
McHeyzer-Williams, L.4
-
142
-
-
79958255209
-
A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center
-
Schwickert, T. A. et al. A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J. Exp. Med. 208, 1243-1252 (2011
-
(2011)
J. Exp. Med
, vol.208
, pp. 1243-1252
-
-
Schwickert, T.A.1
-
143
-
-
84867730760
-
The cell-cycle regulator c Myc is essential for the formation and maintenance of germinal centers
-
Calado, D. P. et al. The cell-cycle regulator c Myc is essential for the formation and maintenance of germinal centers. Nature Immunol. 13, 1092-1100 (2012
-
(2012)
Nature Immunol
, vol.13
, pp. 1092-1100
-
-
Calado, D.P.1
-
144
-
-
84867709361
-
The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
-
Dominguez-Sola, D. et al. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nature Immunol. 13, 1083-1091 (2012
-
(2012)
Nature Immunol
, vol.13
, pp. 1083-1091
-
-
Dominguez-Sola, D.1
-
145
-
-
78149477766
-
Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter
-
Victora, G. D. et al. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 143, 592-605 (2010
-
(2010)
Cell
, vol.143
, pp. 592-605
-
-
Victora, G.D.1
-
146
-
-
84901644301
-
Clonal selection in the germinal centre by regulated proliferation and hypermutation
-
Gitlin, A. D., Shulman, Z. & Nussenzweig, M. C. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature 509, 637-640 (2014
-
(2014)
Nature
, vol.509
, pp. 637-640
-
-
Gitlin, A.D.1
Shulman, Z.2
Nussenzweig, M.C.3
-
147
-
-
4644219817
-
Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
-
DOI 10.1038/ni1100
-
Allen, C. D. et al. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nature Immunol. 5, 943-952 (2004 (Pubitemid 39276239)
-
(2004)
Nature Immunology
, vol.5
, Issue.9
, pp. 943-952
-
-
Allen, C.D.C.1
Ansel, K.M.2
Low, C.3
Lesley, R.4
Tamamura, H.5
Fujii, N.6
Cyster, J.G.7
-
148
-
-
84867163670
-
Molecular pathogenesis of mantle cell lymphoma
-
Jares, P., Colomer, D. & Campo, E. Molecular pathogenesis of mantle cell lymphoma. J. Clin. Invest. 122, 3416-3423 (2012
-
(2012)
J. Clin. Invest
, vol.122
, pp. 3416-3423
-
-
Jares, P.1
Colomer, D.2
Campo, E.3
-
149
-
-
0034598746
-
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
-
DOI 10.1038/35000501
-
Alizadeh, A. A. et al. Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000 (Pubitemid 30082188)
-
(2000)
Nature
, vol.403
, Issue.6769
, pp. 503-511
-
-
Alizadeh, A.A.1
Elsen, M.B.2
Davis, R.E.3
Ma, Ch.L.4
Lossos, I.S.5
Rosenwald, A.6
Boldrick, J.C.7
Sabet, H.8
Tran, T.9
Yu, X.10
Powell, J.I.11
Yang, L.12
Maru, G.E.13
Moore, T.14
Hudson Jr., J.15
Lu, L.16
Lewis, D.B.17
Tibshirani, R.18
Sherlock, G.19
Chan, W.C.20
Greiner, T.C.21
Weisenburger, D.D.22
Armitage, J.O.23
Warnke, R.24
Levy, R.25
Wilson, W.26
Grever, M.R.27
Byrd, J.C.28
Botstein, D.29
Brown, P.O.30
Staudt, L.M.31
more..
-
150
-
-
84866320759
-
Identification of human germinal center light and dark zone cells and their relationship to human B cell lymphomas
-
Victora, G. D. et al. Identification of human germinal center light and dark zone cells and their relationship to human B cell lymphomas. Blood 120, 2240-2248 (2012
-
(2012)
Blood
, vol.120
, pp. 2240-2248
-
-
Victora, G.D.1
-
151
-
-
0025935635
-
Helicobacter pylori-Associated gastritis and primary B cell gastric lymphoma
-
Wotherspoon, A. C., Ortiz-Hidalgo, C., Falzon, M. R. & Isaacson, P. G. Helicobacter pylori-Associated gastritis and primary B cell gastric lymphoma. Lancet 338, 1175-1176 (1991
-
(1991)
Lancet
, vol.338
, pp. 1175-1176
-
-
Wotherspoon, A.C.1
Ortiz-Hidalgo, C.2
Falzon, M.R.3
Isaacson, P.G.4
-
152
-
-
0030045265
-
Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-Associated lymphoid tissue
-
Hussell, T., Isaacson, P. G., Crabtree, J. E. & Spencer, J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-Associated lymphoid tissue. J. Pathol. 178, 122-127 (1996
-
(1996)
J. Pathol
, vol.178
, pp. 122-127
-
-
Hussell, T.1
Isaacson, P.G.2
Crabtree, J.E.3
Spencer, J.4
-
153
-
-
3543066288
-
MALT lymphoma: From morphology to molecules
-
Isaacson, P. G. & Du, M. Q. MALT lymphoma: From morphology to molecules. Nature Rev. Cancer 4, 644-653 (2004 (Pubitemid 39025059)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.8
, pp. 644-653
-
-
Isaacson, P.G.1
Du, M.-Q.2
-
154
-
-
84857942952
-
Discovery and prioritization of somatic mutations in diffuse large B cell lymphoma (DLBCL) by whole-exome sequencing
-
Lohr, J. G. et al. Discovery and prioritization of somatic mutations in diffuse large B cell lymphoma (DLBCL) by whole-exome sequencing. Proc. Natl Acad. Sci. USA 109, 3879-3884 (2012
-
(2012)
Proc. Natl Acad. Sci. USA
, vol.109
, pp. 3879-3884
-
-
Lohr, J.G.1
-
155
-
-
84872856782
-
Genetic heterogeneity of diffuse large B cell lymphoma
-
Zhang, J. et al. Genetic heterogeneity of diffuse large B cell lymphoma. Proc. Natl Acad. Sci. USA 110, 1398-1403 (2013
-
(2013)
Proc. Natl Acad. Sci. USA
, vol.110
, pp. 1398-1403
-
-
Zhang, J.1
-
156
-
-
84876460347
-
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
-
Green, M. R. et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121, 1604-1611 (2013
-
(2013)
Blood
, vol.121
, pp. 1604-1611
-
-
Green, M.R.1
-
157
-
-
84887285547
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
-
Bea, S. et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl Acad. Sci. USA 110, 18250-18255 (2013
-
(2013)
Proc. Natl Acad. Sci. USA
, vol.110
, pp. 18250-18255
-
-
Bea, S.1
-
158
-
-
84866392764
-
Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma
-
Kiel, M. J. et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209, 1553-1565 (2012
-
(2012)
J. Exp. Med
, vol.209
, pp. 1553-1565
-
-
Kiel, M.J.1
-
159
-
-
84870544677
-
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing
-
Richter, J. et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nature Genet. 44, 1316-1320 (2012
-
(2012)
Nature Genet
, vol.44
, pp. 1316-1320
-
-
Richter, J.1
-
160
-
-
84870538715
-
The genetic landscape of mutations in Burkitt lymphoma
-
Love, C. et al. The genetic landscape of mutations in Burkitt lymphoma. Nature Genet. 44, 1321-1325 (2012
-
(2012)
Nature Genet
, vol.44
, pp. 1321-1325
-
-
Love, C.1
-
161
-
-
7044254964
-
Phase II study of denileukin diftitox for relapsed/refractory B-cell non-Hodgkin's lymphoma
-
DOI 10.1200/JCO.2004.03.071
-
Dang, N. H. et al. Phase II study of denileukin diftitox for relapsed/refractory B Cell non-Hodgkins lymphoma. J. Clin. Oncol. 22, 4095-4102 (2004 (Pubitemid 41185178)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.20
, pp. 4095-4102
-
-
Dang, N.H.1
Hagemeister, F.B.2
Pro, B.3
McLaughlin, P.4
Romaguera, J.E.5
Jones, D.6
Samuels, B.7
Samaniego, F.8
Younes, A.9
Wang, M.10
Goy, A.11
Rodriguez, M.A.12
Walker, P.L.13
Arredondo, Y.14
Tong, A.T.15
Fayad, L.16
-
162
-
-
37149001827
-
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497
-
DOI 10.1080/10428190701694186, PII 783033618
-
Kuzel, T. M. et al. Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: Final results of E1497. Leuk. Lymphoma 48, 2397-2402 (2007 (Pubitemid 350253471)
-
(2007)
Leukemia and Lymphoma
, vol.48
, Issue.12
, pp. 2397-2402
-
-
Kuzel, T.M.1
Li, S.2
Eklund, J.3
Foss, F.4
Gascoyne, R.5
Abramson, N.6
Schwerkoske, J.F.7
Weller, E.8
Horning, S.J.9
-
163
-
-
34447299909
-
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
-
DOI 10.1111/j.1365-2141.2007.06684.x
-
Dang, N. H. et al. Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/ refractory B cell non-Hodgkin lymphoma. Br. J. Haematol. 138, 502-505 (2007 (Pubitemid 47063035)
-
(2007)
British Journal of Haematology
, vol.138
, Issue.4
, pp. 502-505
-
-
Dang, N.H.1
Fayad, L.2
McLaughlin, P.3
Romaguara, J.E.4
Hagemeister, F.5
Goy, A.6
Neelapu, S.7
Samaniego, F.8
Walker, P.L.9
Wang, M.10
Rodriguez, M.A.11
Tong, A.T.12
Pro, B.13
-
164
-
-
84860713220
-
Denileukin diftitox in combination with rituximab for previously untreated follicular B cell non-Hodgkins lymphoma
-
Ansell, S. M. et al. Denileukin diftitox in combination with rituximab for previously untreated follicular B cell non-Hodgkins lymphoma. Leukemia 26, 1046-1052 (2012
-
(2012)
Leukemia
, vol.26
, pp. 1046-1052
-
-
Ansell, S.M.1
-
165
-
-
33750704288
-
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients
-
DOI 10.1158/1078-0432.CCR-06-1245
-
Ansell, S. M. et al. Randomized phase II study of interleukin 12 in combination with rituximab in previously treated non-Hodgkins lymphoma patients. Clin. Cancer Res. 12, 6056-6063 (2006 (Pubitemid 44703769)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.20 PART 1
, pp. 6056-6063
-
-
Ansell, S.M.1
Geyer, S.M.2
Maurer, M.J.3
Kurtin, P.J.4
Micallef, I.N.M.5
Stella, P.6
Etzell, P.7
Novak, A.J.8
Erlichman, C.9
Witzig, T.E.10
-
166
-
-
70350244852
-
Phase i study of ipilimumab, an anti-CTLA 4 monoclonal antibody, in patients with relapsed and refractory B cell non-Hodgkin lymphoma
-
Ansell, S. M. et al. Phase I study of ipilimumab, an anti-CTLA 4 monoclonal antibody, in patients with relapsed and refractory B cell non-Hodgkin lymphoma. Clin. Cancer Res. 15, 6446-6453 (2009
-
(2009)
Clin. Cancer Res
, vol.15
, pp. 6446-6453
-
-
Ansell, S.M.1
-
167
-
-
61849165013
-
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
-
Bashey, A. et al. CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation. Blood 113, 1581-1588 (2009
-
(2009)
Blood
, vol.113
, pp. 1581-1588
-
-
Bashey, A.1
-
168
-
-
33847407907
-
A pilot study of CTLA 4 blockade after cancer vaccine failure in patients with advanced malignancy
-
OMahony, D. et al. A pilot study of CTLA 4 blockade after cancer vaccine failure in patients with advanced malignancy. Clin. Cancer Res. 13, 958-964 (2007
-
(2007)
Clin. Cancer Res
, vol.13
, pp. 958-964
-
-
Omahony, D.1
-
169
-
-
49649114804
-
Phase i safety and pharmacokinetic study of CT 011, a humanized antibody interacting with PD 1, in patients with advanced hematologic malignancies
-
Berger, R. et al. Phase I safety and pharmacokinetic study of CT 011, a humanized antibody interacting with PD 1, in patients with advanced hematologic malignancies. Clin. Cancer Res. 14, 3044-3051 (2008
-
(2008)
Clin. Cancer Res
, vol.14
, pp. 3044-3051
-
-
Berger, R.1
-
170
-
-
84890096527
-
Disabling immune tolerance by programmed death 1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B cell lymphoma: Results of an international phase II trial
-
Armand, P. et al. Disabling immune tolerance by programmed death 1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B cell lymphoma: Results of an international phase II trial. J. Clin. Oncol. 31, 4199-4206 (2013
-
(2013)
J. Clin. Oncol
, vol.31
, pp. 4199-4206
-
-
Armand, P.1
-
171
-
-
84891373595
-
Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: A single group, open-label, phase 2 trial
-
Westin, J. R. et al. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: A single group, open-label, phase 2 trial. Lancet Oncol. 15, 69-77 (2014
-
(2014)
Lancet Oncol
, vol.15
, pp. 69-77
-
-
Westin, J.R.1
-
172
-
-
84860712523
-
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
-
Younes, A. et al. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma. Blood 119, 4123-4128 (2012
-
(2012)
Blood
, vol.119
, pp. 4123-4128
-
-
Younes, A.1
-
173
-
-
84860741107
-
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma
-
Kasamon, Y. L. et al. Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma. Blood 119, 4129-4132 (2012
-
(2012)
Blood
, vol.119
, pp. 4129-4132
-
-
Kasamon, Y.L.1
-
174
-
-
39749174407
-
Phase i clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma
-
DOI 10.1158/1078-0432.CCR-07-4435
-
Ansell, S. M. et al. Phase I clinical study of atacicept in patients with relapsed and refractory B cell non-Hodgkins lymphoma. Clin. Cancer Res. 14, 1105-1110 (2008 (Pubitemid 351302557)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.4
, pp. 1105-1110
-
-
Ansell, S.M.1
Witzig, T.E.2
Inwards, D.J.3
Porrata, L.F.4
Ythier, A.5
Ferrande, L.6
Nestorov, I.7
Devries, T.8
Dillon, S.R.9
Hausman, D.10
Novak, A.J.11
-
175
-
-
54449095901
-
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkins lymphoma
-
Wiernik, P. H. et al. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkins lymphoma. J. Clin. Oncol. 26, 4952-4957 (2008
-
(2008)
J. Clin. Oncol
, vol.26
, pp. 4952-4957
-
-
Wiernik, P.H.1
-
176
-
-
64149112784
-
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma
-
Habermann, T. M. et al. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma. Br. J. Haematol. 145, 344-349 (2009
-
(2009)
Br. J. Haematol
, vol.145
, pp. 344-349
-
-
Habermann, T.M.1
-
177
-
-
73949145763
-
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkins lymphoma
-
Witzig, T. E. et al. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkins lymphoma. J. Clin. Oncol. 27, 5404-5409 (2009
-
(2009)
J. Clin. Oncol
, vol.27
, pp. 5404-5409
-
-
Witzig, T.E.1
-
178
-
-
79959722615
-
An international phase II trial of single-Agent lenalidomide for relapsed or refractory aggressive B cell non-Hodgkins lymphoma
-
Witzig, T. E. et al. An international phase II trial of single-Agent lenalidomide for relapsed or refractory aggressive B cell non-Hodgkins lymphoma. Ann. Oncol. 22, 1622-1627 (2011
-
(2011)
Ann. Oncol
, vol.22
, pp. 1622-1627
-
-
Witzig, T.E.1
-
179
-
-
84887030194
-
Long-Term follow up of lenalidomide in relapsed/refractory mantle cell lymphoma: Subset analysis of the NHL 003 study
-
Zinzani, P. L. et al. Long-Term follow up of lenalidomide in relapsed/refractory mantle cell lymphoma: Subset analysis of the NHL 003 study. Ann. Oncol. 24, 2892-2897 (2013
-
(2013)
Ann. Oncol
, vol.24
, pp. 2892-2897
-
-
Zinzani, P.L.1
-
180
-
-
84866875871
-
Single-Agent lenalidomide in relapsed/ refractory mantle cell lymphoma: Results from a UK phase II study suggest activity and possible gender differences
-
Eve, H. E. et al. Single-Agent lenalidomide in relapsed/ refractory mantle cell lymphoma: Results from a UK phase II study suggest activity and possible gender differences. Br. J. Haematol. 159, 154-163 (2012
-
(2012)
Br. J. Haematol
, vol.159
, pp. 154-163
-
-
Eve, H.E.1
-
181
-
-
84889099537
-
Single-Agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: Phase II MCL 001 (EMERGE) study
-
Goy, A. et al. Single-Agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: Phase II MCL 001 (EMERGE) study. J. Clin. Oncol. 31, 3688-3695 (2013
-
(2013)
J. Clin. Oncol
, vol.31
, pp. 3688-3695
-
-
Goy, A.1
-
182
-
-
84874539200
-
A phase II study of lenalidomide in patients with extranodal marginal zone B cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma
-
Kiesewetter, B. et al. A phase II study of lenalidomide in patients with extranodal marginal zone B cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica 98, 353-356 (2013
-
(2013)
Haematologica
, vol.98
, pp. 353-356
-
-
Kiesewetter, B.1
-
183
-
-
81055123994
-
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma
-
Fehniger, T. A. et al. A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma. Blood 118, 5119-5125 (2011
-
(2011)
Blood
, vol.118
, pp. 5119-5125
-
-
Fehniger, T.A.1
-
184
-
-
84857740069
-
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-Angiogenic biomarkers
-
Zaja, F. et al. Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-Angiogenic biomarkers. Haematologica 97, 416-422 (2012
-
(2012)
Haematologica
, vol.97
, pp. 416-422
-
-
Zaja, F.1
-
185
-
-
84863107308
-
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: A phase 1/2 clinical trial
-
Wang, M. et al. Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: A phase 1/2 clinical trial. Lancet Oncol. 13, 716-723 (2012
-
(2012)
Lancet Oncol
, vol.13
, pp. 716-723
-
-
Wang, M.1
-
186
-
-
84857654592
-
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B cell lymphoma: A phase 2 trial
-
Zinzani, P. L. et al. Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B cell lymphoma: A phase 2 trial. Clin. Lymphoma Myeloma Leuk. 11, 462-466 (2011
-
(2011)
Clin. Lymphoma Myeloma Leuk
, vol.11
, pp. 462-466
-
-
Zinzani, P.L.1
-
187
-
-
84883742025
-
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: A phase II clinical trial
-
Wang, M. et al. Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: A phase II clinical trial. Leukemia 27, 1902-1909 (2013
-
(2013)
Leukemia
, vol.27
, pp. 1902-1909
-
-
Wang, M.1
-
188
-
-
84891868901
-
Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas
-
Ahmadi, T. et al. Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas. Cancer 120, 222-228 (2014
-
(2014)
Cancer
, vol.120
, pp. 222-228
-
-
Ahmadi, T.1
-
189
-
-
83555173455
-
Lenalidomide can be safely combined with R CHOP (R2CHOP) in the initial chemotherapy for aggressive B cell lymphomas: Phase i study
-
Nowakowski, G. S. et al. Lenalidomide can be safely combined with R CHOP (R2CHOP) in the initial chemotherapy for aggressive B cell lymphomas: Phase I study. Leukemia 25, 1877-1881 (2011
-
(2011)
Leukemia
, vol.25
, pp. 1877-1881
-
-
Nowakowski, G.S.1
-
190
-
-
84873571469
-
Phase Ib study of lenalidomide in combination with rituximab-CHOP (R2 CHOP) in patients with B cell lymphoma
-
Tilly, H. et al. Phase Ib study of lenalidomide in combination with rituximab-CHOP (R2 CHOP) in patients with B cell lymphoma. Leukemia 27, 252-255 (2013
-
(2013)
Leukemia
, vol.27
, pp. 252-255
-
-
Tilly, H.1
-
191
-
-
84887011781
-
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B cell lymphoma: A phase i study by the Fondazione Italiana Linfomi
-
Chiappella, A. et al. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B cell lymphoma: A phase I study by the Fondazione Italiana Linfomi. Haematologica 98, 1732-1738 (2013
-
(2013)
Haematologica
, vol.98
, pp. 1732-1738
-
-
Chiappella, A.1
-
192
-
-
67650866822
-
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
-
Stopeck, A. T. et al. A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108. Leuk. Lymphoma 50, 728-735 (2009
-
(2009)
Leuk. Lymphoma
, vol.50
, pp. 728-735
-
-
Stopeck, A.T.1
-
193
-
-
84896395732
-
Long-Term follow up of R CHOP with bevacizumab as initial therapy for mantle cell lymphoma: Clinical and correlative results
-
Ruan, J. et al. Long-Term follow up of R CHOP with bevacizumab as initial therapy for mantle cell lymphoma: Clinical and correlative results. Clin. Lymphoma Myeloma Leuk. 14, 107-113 (2014
-
(2014)
Clin. Lymphoma Myeloma Leuk
, vol.14
, pp. 107-113
-
-
Ruan, J.1
-
194
-
-
33646719056
-
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-Associated B cell lymphoma
-
Booman, M. et al. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-Associated B cell lymphoma. Clin. Cancer Res. 12, 2698-2705 (2006
-
(2006)
Clin. Cancer Res
, vol.12
, pp. 2698-2705
-
-
Booman, M.1
-
195
-
-
79960297332
-
Primary central nervous system lymphomas: A validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens
-
Braggio, E. et al. Primary central nervous system lymphomas: A validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens. Clin. Cancer Res. 17, 4245-4253 (2011
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 4245-4253
-
-
Braggio, E.1
-
196
-
-
79251573226
-
Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma
-
Sung, C. O. et al. Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma. Blood 117, 1291-1300 (2011
-
(2011)
Blood
, vol.117
, pp. 1291-1300
-
-
Sung, C.O.1
-
197
-
-
84897530680
-
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B cell lymphoma
-
Twa, D. D. et al. Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B cell lymphoma. Blood 123, 2062-2065 (2014
-
(2014)
Blood
, vol.123
, pp. 2062-2065
-
-
Twa, D.D.1
-
198
-
-
77953526533
-
High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes
-
Cheung, K. J. J. et al. High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes. Genes Chromosome Cancer 49, 669-681 (2010
-
(2010)
Genes Chromosome Cancer
, vol.49
, pp. 669-681
-
-
Cheung, K.J.J.1
-
199
-
-
78549281806
-
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis
-
Cheung, K. J. et al. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res. 70, 9166-9174 (2010
-
(2010)
Cancer Res
, vol.70
, pp. 9166-9174
-
-
Cheung, K.J.1
-
200
-
-
84886290682
-
Mutational and structural analysis of diffuse large B cell lymphoma using whole genome sequencing
-
Morin, R. D. et al. Mutational and structural analysis of diffuse large B cell lymphoma using whole genome sequencing. Blood 122, 1256-1265 (2013
-
(2013)
Blood
, vol.122
, pp. 1256-1265
-
-
Morin, R.D.1
-
201
-
-
79959377393
-
The sphingosine 1 phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement
-
Green, J. A. et al. The sphingosine 1 phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement. Nature Immunol. 12, 672-680 (2011
-
(2011)
Nature Immunol
, vol.12
, pp. 672-680
-
-
Green, J.A.1
-
202
-
-
72249096210
-
Targeted disruption of the S1P2 sphingosine 1 phosphate receptor gene leads to diffuse large B cell lymphoma formation
-
Cattoretti, G. et al. Targeted disruption of the S1P2 sphingosine 1 phosphate receptor gene leads to diffuse large B cell lymphoma formation. Cancer Res. 69, 8686-8692 (2009
-
(2009)
Cancer Res
, vol.69
, pp. 8686-8692
-
-
Cattoretti, G.1
-
203
-
-
80155148301
-
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
-
Oricchio, E. et al. The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 147, 554-564 (2011
-
(2011)
Cell
, vol.147
, pp. 554-564
-
-
Oricchio, E.1
|